Cargando…
Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program
BACKGROUND: In four randomized, controlled, European trials, dienogest 2 mg once daily demonstrated significant efficacy for lesion reduction and reduction in pain intensity in endometriosis. We describe a pooled analysis of the safety and tolerability data from these trials to confirm and further c...
Autores principales: | Strowitzki, Thomas, Faustmann, Thomas, Gerlinger, Christoph, Schumacher, Ulrike, Ahlers, Christiane, Seitz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403681/ https://www.ncbi.nlm.nih.gov/pubmed/25926759 http://dx.doi.org/10.2147/IJWH.S77202 |
Ejemplares similares
-
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
por: Petraglia, Felice, et al.
Publicado: (2011) -
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study
por: Heinemann, Klaas, et al.
Publicado: (2020) -
Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials
por: Gerlinger, Christoph, et al.
Publicado: (2010) -
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials
por: Gerlinger, Christoph, et al.
Publicado: (2012) -
Dienogest and the Risk of Reoperation in Endometriosis
por: Seo, Yong-Soo, et al.
Publicado: (2021)